James Robert Tonra

Title: Innovations of James Robert Tonra

Introduction

James Robert Tonra is a notable inventor based in Skillman, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of two patents to his name, Tonra's work focuses on innovative treatments for various medical conditions.

Latest Patents

Tonra's latest patents include "Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof." This invention is directed to an antibody or fragments thereof that are specific for a fibroblast growth factor receptor (FGFR)-1(IIIb), FGFR-1(IIIc), and/or FGFR-4. The invention also provides methods of antagonizing FGFR-1 or FGFR-4 as a treatment for obesity, diabetes, or related conditions, along with methods of reducing food intake. Another significant patent is for "Anti-FLT3 antibodies," which provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. This invention further outlines methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent, including methotrexate.

Career Highlights

Tonra is currently associated with Imclone LLC, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health issues.

Collaborations

Some of his notable coworkers include Yiwen Li and Dan Lu, who contribute to the collaborative environment that fosters innovation at Imclone LLC.

Conclusion

James Robert Tonra's contributions to biotechnology through his patents and work at Imclone LLC highlight his commitment to advancing medical treatments. His innovative approaches to antibody development are paving the way for new therapeutic options.